An innovative ultrasonography device that has been developed with the future of space health in mind has hitched a ride on SpaceX's Dragon cargo resupply mission. The Translational Research Institute for Space Health, or TRISH, at Baylor College of Medicine is supporting the product's first user demo in space.
The Butterfly iQ device was developed by Connecticut-based Butterfly Network Inc. (NYSE: BFLY) and is "the world's first handheld, single-probe whole-body ultrasound system using semiconductor technology," according to a press release.
TRISH has been supporting the device's development since the organization realized the impact it can have on astronauts' ability to administer their own health care.
"NASA is returning to the moon and our astronauts will need to be more self-reliant when it comes to medical care. TRISH is investing in innovations that enable healthcare to be provided in new ways," says Dr. Dorit Donoviel, director of TRISH, in the release. "On deep space missions, tools such as the Butterfly iQ will help the astronauts monitor themselves for concerns such as kidney stones, fluid in the lungs, blood clots and swelling of the optic nerve."
When the device reaches the International Space Station, the astronauts will provide feedback on how they used the device, the quality of the produced ultrasound images, and the efficiency of image acquisition.
"We're thrilled that TRISH has identified the potential of Butterfly iQ to advance care delivery in remote – and extremely remote – care settings. We are confident that the iQ's combination of diagnostic power, portability, reliability and ease of use will prove a useful addition to the medical toolkit of the International Space Station," said Dr. Todd Fruchterman, president and CEO of Butterfly Network, in the release. "It is an honor to know that a Butterfly device will help NASA safeguard the health of its incredible astronauts by providing actionable diagnostic insights."
The device was recently introduced into CHI St. Luke's Health point of cair practice — specifically for COVID-19 treatment. Dr. Jose Diaz-Gomez, an anesthesiologist and ultrasonography expert at the hospital, says the Butterfly iQ's portable ultrasonography technology has been a key diagnostic tool in his team's point of care for COVID-19 patients.
Moving beyond the pandemic, Diaz-Gomez explained the pertinent use of lower cost, portable ultrasound tools like Butterfly iQ to increase access to health care — even here on earth.
"In conditions that are dynamic, you want to have a diagnostic tool that, over time as you're treating a patient, you can see meaningful changes — good or bad," Diaz-Gomez previously told InnovationMap. "The pandemic has enabled us to use — from the initial care to when they are on the ventilator — ultrasonography to see the changes in the patient's' lungs."
TRISH is focused on identifying and supporting technologies like Butterfly iQ through its network of space health experts, BCM, and NASA, which recently granted renewal for its TRISH partnership granted renewal for its TRISH partnership earlier this year. NASA will continue to work with TRISH to conduct biomedical research geared at protecting astronauts in deep space through 2028.